Literature DB >> 10807547

Molecular cloning and expression analysis of the human DA41 gene and its mapping to chromosome 9q21.2-q21.3.

E Hanaoka1, T Ozaki, M Ohira, Y Nakamura, M Suzuki, E Takahashi, H Moriya, A Nakagawara, S Sakiyama.   

Abstract

DA41 was previously identified as one of the DAN-binding proteins, via a yeast-based two-hybrid screening strategy. In the present study, we cloned a human homolog of DA41 cDNA. Structural analysis revealed that human DA41 cDNA consisted of 2,861 nucleotides in length and encoded a protein of 589 amino acids, with a predicted molecular mass of 62.4kDa. Human DA41 exhibited an 86% amino acid sequence identity to rat DA41, indicating the evolutionarily conserved structure and function of DA41. A database search for DA41-related protein(s) identified mouse PLIC-1, PLIC-2, frog XDRP1, and yeast DSK2. DA41 and each DA41-related protein contain a ubiquitin-like domain in their amino-terminal regions. DA41 was expressed ubiquitously in adult human tissues, with relatively higher levels in pituitary gland, adrenal gland, kidney, thymus, and placenta. Fluorescence in situ hybridization (FISH) revealed that DA41 was mapped to human chromosome 9q21.2-q21.3, a position overlapping the candidate tumor suppressor locus for bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807547     DOI: 10.1007/s100380050209

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  3 in total

1.  The ubiquilin gene family: evolutionary patterns and functional insights.

Authors:  Ignacio Marín
Journal:  BMC Evol Biol       Date:  2014-03-28       Impact factor: 3.260

2.  Overexpression of DA41 in v-Ha-ras-3Y1 cells causes growth suppression.

Authors:  T Ozaki; Y Nakamura; E Hanaoka; A Nakagawara; S Sakiyama
Journal:  Jpn J Cancer Res       Date:  2000-10

3.  Abnormally elevated ubiquilin‑1 expression in breast cancer regulates metastasis and stemness via AKT signaling.

Authors:  Xiaoyue Feng; Anna Cao; Tao Qin; Qingqing Zhang; Shujun Fan; Bo Wang; Bo Song; Xiaotang Yu; Lianhong Li
Journal:  Oncol Rep       Date:  2021-09-16       Impact factor: 3.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.